BACKGROUND: Recent advances enable the direct measurement of small molecule clearance, Kecn, during each dialysis. Average Kecn and treatment length, t, are multiplied giving total clearance, Kt. The body surface area (BSA) is a fixed transformation of height and weight and is a well recognized measure of body size. This project was conceived to search for clinical outcome-based functions for measured Kt in terms of BSA to enable simple Kt prescription guidelines for clinicians who are able to measure Kecn, and to provide foundations for future clinical research. METHODS: The data came from Fresenius Medical Care (NA) files and included more than 32,000 patients with height, weight, and paired Kecn and t measurements during December 2002. Measurements were averaged for the month and used as predictor measures in Cox models of survival time during 2003. Candidate Kt values from 30 L/treatment through 70 were examined to determine the best statistical fit for quintile and decile delimited BSA groups evaluating the best fit Kt treatment target for each group. Functional forms representing the relationship between target Kt values and mean BSA of the groups were then evaluated to determine the best fit. RESULTS: Kt targets increased with BSA in a curvilinear way such that the rate of increase is greater at low BSA than high. The best statistical fit was a double reciprocal form, Kt = 1/(a + b/BSA); "a" and "b" are statistically derived coefficients. The form has an appealing mathematical property; Kt approaches 0 as BSA approaches 0. Other forms fit the data nearly as well, however, and can be used to estimate Kt targets for patients with different BSA. CONCLUSION: Empirical, outcome-based functions of measured Kt in terms of BSA exist and can be used as aids for prescribing and judging hemodialysis treatment.
BACKGROUND: Recent advances enable the direct measurement of small molecule clearance, Kecn, during each dialysis. Average Kecn and treatment length, t, are multiplied giving total clearance, Kt. The body surface area (BSA) is a fixed transformation of height and weight and is a well recognized measure of body size. This project was conceived to search for clinical outcome-based functions for measured Kt in terms of BSA to enable simple Kt prescription guidelines for clinicians who are able to measure Kecn, and to provide foundations for future clinical research. METHODS: The data came from Fresenius Medical Care (NA) files and included more than 32,000 patients with height, weight, and paired Kecn and t measurements during December 2002. Measurements were averaged for the month and used as predictor measures in Cox models of survival time during 2003. Candidate Kt values from 30 L/treatment through 70 were examined to determine the best statistical fit for quintile and decile delimited BSA groups evaluating the best fit Kt treatment target for each group. Functional forms representing the relationship between target Kt values and mean BSA of the groups were then evaluated to determine the best fit. RESULTS: Kt targets increased with BSA in a curvilinear way such that the rate of increase is greater at low BSA than high. The best statistical fit was a double reciprocal form, Kt = 1/(a + b/BSA); "a" and "b" are statistically derived coefficients. The form has an appealing mathematical property; Kt approaches 0 as BSA approaches 0. Other forms fit the data nearly as well, however, and can be used to estimate Kt targets for patients with different BSA. CONCLUSION: Empirical, outcome-based functions of measured Kt in terms of BSA exist and can be used as aids for prescribing and judging hemodialysis treatment.
Authors: Damien Ashby; Natalie Borman; James Burton; Richard Corbett; Andrew Davenport; Ken Farrington; Katey Flowers; James Fotheringham; R N Andrea Fox; Gail Franklin; Claire Gardiner; R N Martin Gerrish; Sharlene Greenwood; Daljit Hothi; Abdul Khares; Pelagia Koufaki; Jeremy Levy; Elizabeth Lindley; Jamie Macdonald; Bruno Mafrici; Andrew Mooney; James Tattersall; Kay Tyerman; Enric Villar; Martin Wilkie Journal: BMC Nephrol Date: 2019-10-17 Impact factor: 2.388
Authors: Sylvia Paz B Ramirez; Alissa Kapke; Friedrich K Port; Robert A Wolfe; Rajiv Saran; Jeffrey Pearson; Richard A Hirth; Joseph M Messana; John T Daugirdas Journal: Clin J Am Soc Nephrol Date: 2012-09-13 Impact factor: 8.237
Authors: Frank J O'Brien; Tammy L Sirich; Abigail Taussig; Enrica Fung; Lakshmi L Ganesan; Natalie S Plummer; Paul Brakeman; Scott M Sutherland; Timothy W Meyer Journal: Pediatr Nephrol Date: 2019-11-14 Impact factor: 3.714
Authors: G Martínez Fernández; A Ortega Cerrato; J Masiá Mondéjar; A Pérez Rodríguez; F Llamas Fuentes; C Gómez Roldán; Juan Pérez-Martínez Journal: Clin Exp Nephrol Date: 2012-08-11 Impact factor: 2.801
Authors: John T Daugirdas; Nathan W Levin; Peter Kotanko; Thomas A Depner; Martin K Kuhlmann; Glenn M Chertow; Michael V Rocco Journal: Semin Dial Date: 2008 Sep-Oct Impact factor: 3.455
Authors: John T Daugirdas; Thomas A Depner; Tom Greene; Martin K Kuhlmann; Nathan W Levin; Glenn M Chertow; Michael V Rocco Journal: Semin Dial Date: 2008 Sep-Oct Impact factor: 3.455